The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.
Completed · Phase 1 · Has a placebo group
Conditions studied: Liver Disease
In brief
The purpose of this study is to determine whether dosing tropifexor is safe and tolerable.
Key facts
- Study ID
- NCT04408937
- Run by
- Novartis Pharmaceuticals
- People needed
- 89
- Starts
- 2020-05-29
- Expected to finish
- 2020-11-04
- Last updated by the study team
- 2022-02-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Presence of Liver Disease
You may not qualify if…
- Use of other investigational drugs at the time of enrollment, or within 5 half-lives of enrollment, or within 30 days, whichever is longer; or longer if required by local regulations.
- Subjects taking the following medicines UNLESS on a stable dose (within 25% of baseline dose) for at least 3 months before randomization:
- Type 1 diabetes and Uncontrolled Type 2 diabetes defined as Glycated hemoglobin (HbAlc) ≥ 9.5% at screening
- Calculated estimated glomerular filtration rate (eGFR) ≤ 60 mL/min/1.73m2 (using the Modification of diet in renal disease (MDRD) formula) Subjects with contraindications to Magnetic resonance imaging (MRI) imaging.
Where it is running
- Novartis Investigative Site — Madison, Alabama, United States
- Novartis Investigative Site — Coronado, California, United States
- Novartis Investigative Site — Miami, Florida, United States
- Novartis Investigative Site — Pensacola, Florida, United States
- Novartis Investigative Site — South Bend, Indiana, United States
- Novartis Investigative Site — Morehead City, North Carolina, United States
- Novartis Investigative Site — Hermitage, Tennessee, United States
- Novartis Investigative Site — Knoxville, Tennessee, United States
- Novartis Investigative Site — Dallas, Texas, United States
- Novartis Investigative Site — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.